For: | Zheng SJ, Zheng SP, Huang FY, Jiao CL, Wu RL. Synergistic anti-tumor effect of recombinant chicken fibroblast growth factor receptor-1-mediated anti-angiogenesis and low-dose gemcitabine in a mouse colon adenocarcinoma model. World J Gastroenterol 2007; 13(17): 2484-2489 [PMID: 17552033 DOI: 10.3748/wjg.v13.i17.2484] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i17/2484.htm |
Number | Citing Articles |
1 |
Samuel C. Wagner, Thomas E. Ichim, Hong Ma, Julia Szymanski, Jesus A. Perez, Javier Lopez, Vladimir Bogin, Amit N. Patel, Francisco M. Marincola, Santosh Kesari. Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique?. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0688-5
|
2 |
Shaoping Zheng, Zhihong Weng, Shaojiang Zheng, Junli Guo, Fengying Huang, Mingxing Xie. Anti-tumor angiogenesis with a recombinant ag43/FGFR1 chimeric protein as a model antigen. Journal of Huazhong University of Science and Technology [Medical Sciences] 2010; 30(1): 25 doi: 10.1007/s11596-010-0105-5
|
3 |
Y. Diaz, Y. Tundidor, A. Lopez, K. Leon. Concomitant combination of active immunotherapy and carboplatin- or paclitaxel-based chemotherapy improves anti-tumor response. Cancer Immunology, Immunotherapy 2013; 62(3): 455 doi: 10.1007/s00262-012-1345-y
|
4 |
Vladan Milosevic, Reidunn J. Edelmann, Johanna Hol Fosse, Arne Östman, Lars A. Akslen. Biomarkers of the Tumor Microenvironment. 2022; : 31 doi: 10.1007/978-3-030-98950-7_3
|
5 |
Tianqian Zhang, Dorothee Herlyn. Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer. Cancer Immunology, Immunotherapy 2009; 58(4): 475 doi: 10.1007/s00262-008-0598-y
|
6 |
James L. Frazier, James E. Han, Michael Lim, Alessandro Olivi. Immunotherapy Combined with Chemotherapy in the Treatment of Tumors. Neurosurgery Clinics of North America 2010; 21(1): 187 doi: 10.1016/j.nec.2009.09.003
|
7 |
Chun-Bin Tung, Chia-Ying Li, Hung-Yu Lin. Multi-Omics Reveal the Immunological Role and the Theragnostic Value of miR-216a/GDF15 Axis in Human Colon Adenocarcinoma. International Journal of Molecular Sciences 2021; 22(24): 13636 doi: 10.3390/ijms222413636
|
8 |
Congcong Lin, Huei Ng, Weisan Pan, Hubiao Chen, Ge Zhang, Zhaoxiang Bian, Aiping Lu, Zhijun Yang. Exploring Different Strategies for Efficient Delivery of Colorectal Cancer Therapy. International Journal of Molecular Sciences 2015; 16(11): 26936 doi: 10.3390/ijms161125995
|
9 |
Begum Dariya, Neha Merchant, Sheik Aliya, Afroz Alam, Ganji Purnachandra Nagaraju. Role of Tyrosine Kinases in Gastrointestinal Malignancies. 2018; : 141 doi: 10.1007/978-981-13-1486-5_11
|
10 |
Yoko Matsuda, Junji Ueda, Toshiyuki Ishiwata. Fibroblast Growth Factor Receptor 2: Expression, Roles, and Potential As a Novel Molecular Target for Colorectal Cancer. Pathology Research International 2012; 2012: 1 doi: 10.1155/2012/574768
|
11 |
Marwa A. Sallam, Supriya Prakash, Vinu Krishnan, Kristina Todorova, Anna Mandinova, Samir Mitragotri. Hyaluronic Acid Conjugates of Vorinostat and Bexarotene for Treatment of Cutaneous Malignancies. Advanced Therapeutics 2020; 3(10) doi: 10.1002/adtp.202000116
|